Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes.
Evgenia FoteinopoulouCatriona A L ClarkeRebecca J PattendenStuart A RitchieEmily M McMurrayRebecca M ReynoldsGanesan ArunagirinathanFraser W GibbJohn A McKnightMark W J StrachanPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
Serum C-peptide testing can easily be incorporated into an out-patient clinic setting and could be a cost-effective intervention. C-peptide testing should be strongly considered in individuals with a clinician-diagnosis of type 1 diabetes of at least 3 years duration.